IQHQ – a premier owner and developer of life science districts – announced that $900 million of new capital was raised in 2024, with the most recent closing occurring in December 2024.
IQHQ’s districts are designed to provide best-in-class lab and research space with unparalleled amenities and easy access to transportation. And the capital raise was supported by a strong year of leasing activity in 2024, having executed a total of 400,000 sq. ft. of life science and retail leases through year-end. And the new capital funding gives additional momentum to IQHQ’s business during a period of rapidly improving fundamentals for the life science sector, which has further increased the Company’s pipeline of active negotiations and prospects.
KEY QUOTES:
“These capital rounds, which were led by existing institutional equity investors in IQHQ, demonstrate the long-standing conviction of IQHQ’s investors to its business and the robust outlook for life science real estate to create value for shareholders. Our proven ability to raise and allocate capital in the life science sector is a testament to the strength of IQHQ’s strategy, team, and projects that sit at the forefront of innovation.”
– Tyler Rose, IQHQ President and Chief Financial Officer
“Industry leaders are gravitating to our urban hubs of innovation which attract top talent and provide our partners with flexible research space to advance breakthroughs in health and technology. We intend to continue executing on key projects in the first quarter and are well-situated to build on our strategy throughout 2025 and beyond, further solidifying IQHQ’s position as the preeminent developer of world-class life science districts.”
– Stephen Rosetta, IQHQ Co-CEO and Co-Founder
